SECOND REGULAR SESSION
SENATE BILL NO. 1128
102ND GENERA L ASSEMBLY
INTRODUCED BY SENATOR MCCREERY.
4303S.01I KRISTINA MARTIN, Secretary
AN ACT
To repeal section 338.010, RSMo, and to enact in lieu thereof two new sections relating to
contraceptives.
Be it enacted by the General Assembly of the State of Missouri, as follows:
1 Section A. Section 338.010, RSMo, is repealed and two new
2 sections enacted in lieu thereof, to be known as sections
3 338.010 and 338.720, to read as follows:
1 338.010. 1. The "practice of pharmacy" includes:
2 (1) The interpretation, implementation, and evaluation
3 of medical prescription orders, including any legend drugs
4 under 21 U.S.C. Section 353, and the receipt, transmission,
5 or handling of such orders or facilitating the dispensing of
6 such orders;
7 (2) The designing, initiating, implementing, and
8 monitoring of a medication therapeutic plan in accordance
9 with the provisions of this section;
10 (3) The compounding, dispensing, labeling, and
11 administration of drugs and devices pursuant to medical
12 prescription orders;
13 (4) The ordering and administration of vaccines
14 approved or authorized by the U.S. Food and Drug
15 Administration, excluding vaccines for cholera, monkeypox,
16 Japanese encephalitis, typhoid, rabies, yellow fever, tick-
17 borne encephalitis, anthrax, tuberculosis, dengue, Hib,
18 polio, rotavirus, smallpox, and any vaccine approved after
EXPLANATION-Matter enclosed in bold-faced brackets [thus] in this bill is not enacted
and is intended to be omitted in the law.
SB 1128 2
19 January 1, 2023, to persons at least seven years of age or
20 the age recommended by the Centers for Disease Control and
21 Prevention, whichever is older, pursuant to joint
22 promulgation of rules established by the board of pharmacy
23 and the state board of registration for the healing arts
24 unless rules are established under a state of emergency as
25 described in section 44.100;
26 (5) The participation in drug selection according to
27 state law and participation in drug utilization reviews;
28 (6) The proper and safe storage of drugs and devices
29 and the maintenance of proper records thereof;
30 (7) Consultation with patients and other health care
31 practitioners, and veterinarians and their clients about
32 legend drugs, about the safe and effective use of drugs and
33 devices;
34 (8) The prescribing and dispensing of any nicotine
35 replacement therapy product under section 338.665;
36 (9) The dispensing of HIV postexposure prophylaxis
37 pursuant to section 338.730; [and]
38 (10) The dispensing of self-administered hormonal
39 contraceptives under section 338.720; and
40 (11) The offering or performing of those acts,
41 services, operations, or transactions necessary in the
42 conduct, operation, management and control of a pharmacy.
43 2. No person shall engage in the practice of pharmacy
44 unless he or she is licensed under the provisions of this
45 chapter.
46 3. This chapter shall not be construed to prohibit the
47 use of auxiliary personnel under the direct supervision of a
48 pharmacist from assisting the pharmacist in any of his or
49 her duties. This assistance in no way is intended to
50 relieve the pharmacist from his or her responsibilities for
SB 1128 3
51 compliance with this chapter and he or she will be
52 responsible for the actions of the auxiliary personnel
53 acting in his or her assistance.
54 4. This chapter shall not be construed to prohibit or
55 interfere with any legally registered practitioner of
56 medicine, dentistry, or podiatry, or veterinary medicine
57 only for use in animals, or the practice of optometry in
58 accordance with and as provided in sections 195.070 and
59 336.220 in the compounding, administering, prescribing, or
60 dispensing of his or her own prescriptions.
61 5. A pharmacist with a certificate of medication
62 therapeutic plan authority may provide medication therapy
63 services pursuant to a written protocol from a physician
64 licensed under chapter 334 to patients who have established
65 a physician-patient relationship, as described in
66 subdivision (1) of subsection 1 of section 191.1146, with
67 the protocol physician. The written protocol authorized by
68 this section shall come only from the physician and shall
69 not come from a nurse engaged in a collaborative practice
70 arrangement under section 334.104, or from a physician
71 assistant engaged in a collaborative practice arrangement
72 under section 334.735.
73 6. Nothing in this section shall be construed as to
74 prevent any person, firm or corporation from owning a
75 pharmacy regulated by sections 338.210 to 338.315, provided
76 that a licensed pharmacist is in charge of such pharmacy.
77 7. Nothing in this section shall be construed to apply
78 to or interfere with the sale of nonprescription drugs and
79 the ordinary household remedies and such drugs or medicines
80 as are normally sold by those engaged in the sale of general
81 merchandise.
SB 1128 4
82 8. No health carrier as defined in chapter 376 shall
83 require any physician with which they contract to enter into
84 a written protocol with a pharmacist for medication
85 therapeutic services.
86 9. This section shall not be construed to allow a
87 pharmacist to diagnose or independently prescribe
88 pharmaceuticals.
89 10. The state board of registration for the healing
90 arts, under section 334.125, and the state board of
91 pharmacy, under section 338.140, shall jointly promulgate
92 rules regulating the use of protocols for medication therapy
93 services. Such rules shall require protocols to include
94 provisions allowing for timely communication between the
95 pharmacist and the protocol physician or similar body
96 authorized by this section, and any other patient protection
97 provisions deemed appropriate by both boards. In order to
98 take effect, such rules shall be approved by a majority vote
99 of a quorum of each board. Neither board shall separately
100 promulgate rules regulating the use of protocols for
101 medication therapy services. Any rule or portion of a rule,
102 as that term is defined in section 536.010, that is created
103 under the authority delegated in this section shall become
104 effective only if it complies with and is subject to all of
105 the provisions of chapter 536 and, if applicable, section
106 536.028. This section and chapter 536 are nonseverable and
107 if any of the powers vested with the general assembly
108 pursuant to chapter 536 to review, to delay the effective
109 date, or to disapprove and annul a rule are subsequently
110 held unconstitutional, then the grant of rulemaking
111 authority and any rule proposed or adopted after August 28,
112 2007, shall be invalid and void.
SB 1128 5
113 11. The state board of pharmacy may grant a
114 certificate of medication therapeutic plan authority to a
115 licensed pharmacist who submits proof of successful
116 completion of a board-approved course of academic clinical
117 study beyond a bachelor of science in pharmacy, including
118 but not limited to clinical assessment skills, from a
119 nationally accredited college or university, or a
120 certification of equivalence issued by a nationally
121 recognized professional organization and approved by the
122 board of pharmacy.
123 12. Any pharmacist who has received a certificate of
124 medication therapeutic plan authority may engage in the
125 designing, initiating, implementing, and monitoring of a
126 medication therapeutic plan as defined by a written protocol
127 from a physician that may be specific to each patient for
128 care by a pharmacist.
129 13. Nothing in this section shall be construed to
130 allow a pharmacist to make a therapeutic substitution of a
131 pharmaceutical prescribed by a physician unless authorized
132 by the written protocol or the physician's prescription
133 order.
134 14. "Veterinarian", "doctor of veterinary medicine",
135 "practitioner of veterinary medicine", "DVM", "VMD", "BVSe",
136 "BVMS", "BSe (Vet Science)", "VMB", "MRCVS", or an
137 equivalent title means a person who has received a doctor's
138 degree in veterinary medicine from an accredited school of
139 veterinary medicine or holds an Educational Commission for
140 Foreign Veterinary Graduates (EDFVG) certificate issued by
141 the American Veterinary Medical Association (AVMA).
142 15. In addition to other requirements established by
143 the joint promulgation of rules by the board of pharmacy and
144 the state board of registration for the healing arts:
SB 1128 6
145 (1) A pharmacist shall administer vaccines by protocol
146 in accordance with treatment guidelines established by the
147 Centers for Disease Control and Prevention (CDC);
148 (2) A pharmacist who is administering a vaccine shall
149 request a patient to remain in the pharmacy a safe amount of
150 time after administering the vaccine to observe any adverse
151 reactions. Such pharmacist shall have adopted emergency
152 treatment protocols.
153 16. In addition to other requirements by the board, a
154 pharmacist shall receive additional training as required by
155 the board and evidenced by receiving a certificate from the
156 board upon completion, and shall display the certification
157 in his or her pharmacy where vaccines are delivered.
158 17. A pharmacist shall inform the patient that the
159 administration of a vaccine will be entered into the
160 ShowMeVax system, as administered by the department of
161 health and senior services. The patient shall attest to the
162 inclusion of such information in the system by signing a
163 form provided by the pharmacist. If the patient indicates
164 that he or she does not want such information entered into
165 the ShowMeVax system, the pharmacist shall provide a written
166 report within fourteen days of administration of a vaccine
167 to the patient's health care provider, if provided by the
168 patient, containing:
169 (1) The identity of the patient;
170 (2) The identity of the vaccine or vaccines
171 administered;
172 (3) The route of administration;
173 (4) The anatomic site of the administration;
174 (5) The dose administered; and
175 (6) The date of administration.
SB 1128 7
176 18. A pharmacist licensed under this chapter may order
177 and administer vaccines approved or authorized by the U.S.
178 Food and Drug Administration to address a public health
179 need, as lawfully authorized by the state or federal
180 government, or a department or agency thereof, during a
181 state or federally declared public health emergency.
1 338.720. 1. For purposes of this section, the term
2 "self-administered hormonal contraceptive" shall mean a drug
3 composed of one or more hormones that is approved by the
4 United States Food and Drug Administration to prevent
5 pregnancy.
6 2. A pharmacist may dispense self-administered
7 hormonal contraceptives to a person under a prescription
8 order for medication therapy services as described in
9 section 338.010. A prescription order for a self-
10 administered hormonal contraceptive shall have no expiration
11 date.
12 3. The board of pharmacy, under section 338.140, and
13 the board of registration for the healing arts, under
14 section 334.125, shall jointly promulgate rules regulating
15 the use of protocols for prescription orders for self-
16 administered hormonal contraceptives. Any rule or portion
17 of a rule, as that term is defined in section 536.010, that
18 is created under the authority delegated in this section
19 shall become effective only if it complies with and is
20 subject to all of the provisions of chapter 536 and, if
21 applicable, section 536.028. This section and chapter 536
22 are nonseverable, and if any of the powers vested with the
23 general assembly pursuant to chapter 536 to review, to delay
24 the effective date, or to disapprove and annul a rule are
25 subsequently held unconstitutional, then the grant of
SB 1128 8
26 rulemaking authority and any rule proposed or adopted after
27 August 28, 2024, shall be invalid and void.
28 4. The rules adopted under this section shall require
29 a pharmacist to:
30 (1) Complete a training program approved by the board
31 of pharmacy that is related to dispensing self-administered
32 hormonal contraceptives under this section;
33 (2) Provide a self-screening risk assessment tool that
34 the patient shall use prior to the pharmacist's dispensing
35 the self-administered hormonal contraceptive under this
36 section;
37 (3) At least once every twelve months, verbally refer
38 the patient to the health care provider with whom the
39 pharmacist has a prescription order before dispensing the
40 self-administered hormonal contraceptive to the patient;
41 (4) Provide the patient with a written record of the
42 self-administered hormonal contraceptive dispensed and
43 advise the patient to consult with a health care provider;
44 and
45 (5) Dispense the self-administered hormonal
46 contraceptive to the patient as soon as practicable.
47 5. All state and federal laws governing insurance
48 coverage of contraceptive drugs, devices, products, and
49 services shall apply to self-administered hormonal
50 contraceptives dispensed by a pharmacist under this section.
51 6. Nothing in this section shall be construed to allow
52 a pharmacist to make a therapeutic substitution of a
53 pharmaceutical prescribed by a physician unless authorized
54 by the written protocol or the physician's written
55 prescription order.
